Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-11-04

Clinical Trial Update: Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid [NA]

View source ↗

Summary

This clinical trial update compares atorvastatin monotherapy to the combination of atorvastatin with fenofibric acid for dyslipidemia, focusing on efficacy and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fenofibric acid (fenofibric acid)
  • atorvastatin (atorvastatin)

Snippet

Sponsor: Sang Hak Lee | Conditions: Mixed Hyperlipidemia | NA | Status: UNKNOWN